|
DIXDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.380100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.106100E-02 |
| Normal-vs-Stage2 |
1.344650E-01 |
| Normal-vs-Stage3 |
7.393000E-01 |
| Normal-vs-Stage4 |
3.26679999995694E-06 |
| Stage1-vs-Stage2 |
6.099000E-01 |
| Stage1-vs-Stage3 |
2.975800E-01 |
| Stage1-vs-Stage4 |
2.04699999950542E-07 |
| Stage2-vs-Stage3 |
2.495800E-01 |
| Stage2-vs-Stage4 |
9.792200E-04 |
| Stage3-vs-Stage4 |
1.587240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.554200E-02 |
| Normal-vs-AfricanAmerican |
4.343200E-01 |
| Normal-vs-Asian |
5.397800E-01 |
| Caucasian-vs-AfricanAmerican |
8.745000E-01 |
| Caucasian-vs-Asian |
3.345000E-01 |
| AfricanAmerican-vs-Asian |
4.370600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.690780E-01 |
| Normal-vs-Female |
1.079420E-01 |
| Male-vs-Female |
3.206600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.674200E-01 |
| Normal-vs-Extreme_Weight |
7.278200E-01 |
| Normal-vs-Obese |
5.154400E-02 |
| Normal-vs-Extreme_Obese |
1.356240E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.632400E-01 |
| Normal_Weight-vs-Obese |
3.505800E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.404800E-01 |
| Extreme_Weight-vs-Obese |
9.456300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.141600E-01 |
| Obese-vs-Extreme_Obese |
1.130090E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.688400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.056400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.846800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.507200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.082650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.549400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.142400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.874100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.160400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.910340E-02 |
| Normal-VS-Type2 PRCC |
9.618200E-01 |
| Normal-VS-KIRP CIMP |
5.02270000035665E-08 |
| Normal-VS-Unclassified PRCC |
4.418400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.098790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.81709980395794E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
2.477200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.69965999999855E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.408300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.012830E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.054200E-01 |
| Normal-vs-N1 |
6.791400E-04 |
| Normal-vs-N2 |
9.366100E-04 |
| N0-vs-N1 |
3.527800E-02 |
| N0-vs-N2 |
3.957700E-03 |
| N1-vs-N2 |
2.215200E-01 |
|
|
